Dexmedetomidine Versus Pentobarbital for Pediatric Procedural Sedation

Withdrawn before enrolling · Not applicable

Conditions studied: Sedation

In brief

The investigators believe dexmedetomidine will provide superior sedation with reduced side effects and reduced time to discharge compared with pentobarbital. The investigators have developed sedation protocols with pentobarbital and dexmedetomidine in our ambulatory procedure center. These protocols are both routinely used for sedation in our unit. The investigators propose to study these two protocols in children ages 6 months to 6 years presenting to the ambulatory procedure center for non-painful procedural sedation. The investigators will compare failure of sedation, side effect profile, recovery and discharge times between the two pharmacologic protocols.

Key facts

Study ID

NCT00878345

Run by

Washington University School of Medicine

People needed

0

Starts

2009-11-01

Expected to finish

2010-06-01

Last updated by the study team

2018-06-28

Who can join

Age: 1 and older, up to 6. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Requiring sedation for non-painful procedures
• Normal airway per exam

You may not qualify if…

• Congenital syndromes with known difficult airways
• Known difficult airway during past anesthesia or sedation experience
• Parent/guardian refusal of participation

Where it is running

• St. Louis Children's Hospital — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.